BAKER BROS. ADVISORS LP Diversified Active

Location: New York, NY

CIK: 0001263508 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $19.96B (99.7% shares, 0.3% debt)

Holdings (84)

INCY Incyte Corporation 17.5%
Value $3.487B Shares 30,762,330 Est. Cost Unrealized
ONC BeOne Medicines Ltd. 12.6%
Value $2.508B Shares 8,801,567 Est. Cost Unrealized
RVMD Revolution Medicines, Inc. 10.7%
Value $2.143B Shares 11,443,357 Est. Cost Unrealized
MDGL Madrigal Pharmaceuticals, Inc. 5.8%
Value $1.151B Shares 2,143,131 Est. Cost Unrealized
ACAD ACADIA Pharmaceuticals Inc. 5.4%
Value $1.086B Shares 42,912,904 Est. Cost Unrealized
KYMR Kymera Therapeutics, Inc. 5.0%
Value $993M Shares 8,657,242 Est. Cost Unrealized
INSM Insmed Incorporated 4.7%
Value $938M Shares 8,796,111 Est. Cost Unrealized
CELC Celcuity Inc. 4.2%
Value $828M Shares 7,915,792 Est. Cost Unrealized
KOD Kodiak Sciences Inc. 3.9%
Value $776M Shares 19,919,186 Est. Cost Unrealized
RYTM Rhythm Pharmaceuticals, Inc. 3.1%
Value $622M Shares 5,604,483 Est. Cost Unrealized
PRAX Praxis Precision Medicines, Inc. 2.9%
Value $587M Shares 1,753,198 Est. Cost Unrealized
ALKS Alkermes plc 2.6%
Value $525M Shares 10,012,267 Est. Cost Unrealized
SMMT Summit Therapeutics Inc. 2.4%
Value $478M Shares 32,786,348 Est. Cost Unrealized
GRAL GRAIL, Inc. 1.4%
Value $275M Shares 4,028,614 Est. Cost Unrealized
ABCL AbCellera Biologics Inc. 1.3%
Value $259M Shares 33,012,138 Est. Cost Unrealized
IMVT Immunovant, Inc. 1.0%
Value $209M Shares 5,435,220 Est. Cost Unrealized
IDYA IDEAYA Biosciences, Inc. 0.9%
Value $187M Shares 5,010,030 Est. Cost Unrealized
KNSA Kiniksa Pharmaceuticals International, plc 0.9%
Value $181M Shares 2,834,643 Est. Cost Unrealized
ROIV Roivant Sciences Ltd. 0.8%
Value $167M Shares 4,716,831 Est. Cost Unrealized
ARWR Arrowhead Pharmaceuticals, Inc. 0.8%
Value $162M Shares 1,992,783 Est. Cost Unrealized
IONS Ionis Pharmaceuticals, Inc. 0.8%
Value $162M Shares 2,047,727 Est. Cost Unrealized
EWTX Edgewise Therapeutics, Inc. 0.8%
Value $150M Shares 3,701,719 Est. Cost Unrealized
REPL Replimune Group, Inc. 0.6%
Value $122M Shares 11,045,336 Est. Cost Unrealized
NRIX Nurix Therapeutics, Inc. 0.6%
Value $113M Shares 4,658,556 Est. Cost Unrealized
STOK Stoke Therapeutics, Inc. 0.5%
Value $109M Shares 3,336,697 Est. Cost Unrealized
GLUE Monte Rosa Therapeutics, Inc. 0.5%
Value $105M Shares 4,345,736 Est. Cost Unrealized
IMTX Immatics N.V. 0.5%
Value $96.32M Shares 9,508,565 Est. Cost Unrealized
DNLI Denali Therapeutics Inc. 0.5%
Value $96.05M Shares 3,734,336 Est. Cost Unrealized
CRNX Crinetics Pharmaceuticals, Inc. 0.4%
Value $87.99M Shares 2,351,465 Est. Cost Unrealized
DNTH Dianthus Therapeutics, Inc. 0.4%
Value $83.07M Shares 852,164 Est. Cost Unrealized
GPCR Structure Therapeutics Inc. 0.4%
Value $76.88M Shares 1,432,529 Est. Cost Unrealized
Celcuity Inc. 0.3%
Value $69.16M Shares 30,750,000 Est. Cost Unrealized
RAPP Rapport Therapeutics, Inc. 0.3%
Value $64.47M Shares 1,547,090 Est. Cost Unrealized
ALMS Alumis Inc. 0.3%
Value $56.63M Shares 2,012,500 Est. Cost Unrealized
PRLD Prelude Therapeutics Inc. 0.3%
Value $53.96M Shares 10,123,824 Est. Cost Unrealized
RLAY Relay Therapeutics, Inc. 0.3%
Value $52.89M Shares 2,826,783 Est. Cost Unrealized
MIRM Mirum Pharmaceuticals, Inc. 0.3%
Value $52.21M Shares 445,975 Est. Cost Unrealized
BCYC Bicycle Therapeutics plc 0.2%
Value $46.15M Shares 10,885,357 Est. Cost Unrealized
ELVN Enliven Therapeutics, Inc. 0.2%
Value $45.94M Shares 905,191 Est. Cost Unrealized
CLDX Celldex Therapeutics, Inc. 0.2%
Value $44M Shares 1,182,611 Est. Cost Unrealized
VRDN Viridian Therapeutics, Inc. 0.2%
Value $43.78M Shares 2,383,025 Est. Cost Unrealized
DSGN Design Therapeutics, Inc. 0.2%
Value $38.76M Shares 2,678,430 Est. Cost Unrealized
TRDA Entrada Therapeutics, Inc. 0.2%
Value $37.34M Shares 5,072,730 Est. Cost Unrealized
SNSE Faeth Therapeutics, Inc. 0.2%
Value $32.16M Shares 1,286,411 Est. Cost Unrealized
AKTS Aktis Oncology, Inc. 0.2%
Value $32.11M Shares 996,351 Est. Cost Unrealized
NGNE Neurogene Inc. 0.2%
Value $31.19M Shares 991,691 Est. Cost Unrealized
JBIO Jade Biosciences, Inc. 0.1%
Value $27.34M Shares 1,230,426 Est. Cost Unrealized
TSHA Taysha Gene Therapies, Inc. 0.1%
Value $27.27M Shares 4,004,756 Est. Cost Unrealized
RCUS Arcus Biosciences, Inc. 0.1%
Value $26.05M Shares 844,816 Est. Cost Unrealized
IRON Disc Medicine, Inc. 0.1%
Value $25.57M Shares 349,657 Est. Cost Unrealized
ABSI Absci Corporation 0.1%
Value $24.74M Shares 2,134,803 Est. Cost Unrealized
GENB Generate Biomedicines, Inc. 0.1%
Value $24.02M Shares 1,423,602 Est. Cost Unrealized
DBVT DBV Technologies S.A. 0.1%
Value $23.97M Shares 1,461,425 Est. Cost Unrealized
XENE Xenon Pharmaceuticals Inc. 0.1%
Value $22.35M Shares 370,208 Est. Cost Unrealized
TECX Tectonic Therapeutic, Inc. 0.1%
Value $20.89M Shares 607,788 Est. Cost Unrealized
CERS Cerus Corporation 0.1%
Value $18.67M Shares 6,395,431 Est. Cost Unrealized
CTMX CytomX Therapeutics, Inc. 0.1%
Value $18.66M Shares 4,975,826 Est. Cost Unrealized
DYN Dyne Therapeutics, Inc. 0.1%
Value $18.07M Shares 813,449 Est. Cost Unrealized
CYTK Cytokinetics, Incorporated 0.1%
Value $18M Shares 211,267 Est. Cost Unrealized
XNCR Xencor, Inc. 0.1%
Value $17.74M Shares 1,102,106 Est. Cost Unrealized
SION Sionna Therapeutics, Inc. 0.1%
Value $17.6M Shares 400,000 Est. Cost Unrealized
NTLA Intellia Therapeutics, Inc. 0.1%
Value $15.74M Shares 930,232 Est. Cost Unrealized
PBLS Parabilis Medicines, Inc. 0.1%
Value $13.69M Shares 500,000 Est. Cost Unrealized
MPLT MapLight Therapeutics, Inc. 0.1%
Value $13.07M Shares 364,705 Est. Cost Unrealized
AVLN Avalyn Pharma Inc. 0.1%
Value $11.52M Shares 350,000 Est. Cost Unrealized
EVMN Evommune, Inc. 0.1%
Value $11.26M Shares 847,390 Est. Cost Unrealized
BNTX BioNTech SE 0.1%
Value $11.14M Shares 119,743 Est. Cost Unrealized
TNGX Tango Therapeutics, Inc. 0.1%
Value $10.42M Shares 333,333 Est. Cost Unrealized
AVTX Avalo Therapeutics, Inc. 0.1%
Value $10.16M Shares 550,000 Est. Cost Unrealized
SERA Sera Prognostics, Inc. 0.1%
Value $10.01M Shares 5,498,170 Est. Cost Unrealized
VSTM Verastem, Inc. 0.0%
Value $9.547M Shares 2,499,338 Est. Cost Unrealized
SGMT Sagimet Biosciences Inc. 0.0%
Value $7.367M Shares 952,996 Est. Cost Unrealized
EIKN Eikon Therapeutics, Inc. 0.0%
Value $7.25M Shares 555,555 Est. Cost Unrealized
LBRX LB Pharmaceuticals Inc. 0.0%
Value $6.491M Shares 200,000 Est. Cost Unrealized
VTVT vTv Therapeutics, Inc. 0.0%
Value $5.584M Shares 148,314 Est. Cost Unrealized
WVE Wave Life Sciences Ltd. 0.0%
Value $4.78M Shares 822,638 Est. Cost Unrealized
TARA Protara Therapeutics, Inc. 0.0%
Value $3.712M Shares 971,614 Est. Cost Unrealized
TCRX TScan Therapeutics, Inc. 0.0%
Value $2.729M Shares 2,784,792 Est. Cost Unrealized
IMNM Immunome, Inc. 0.0%
Value $1.172M Shares 55,306 Est. Cost Unrealized
SKYE Skye Bioscience, Inc. 0.0%
Value $1.092M Shares 1,575,243 Est. Cost Unrealized
SANA Sana Biotechnology, Inc. 0.0%
Value $1.084M Shares 310,483 Est. Cost Unrealized
ALGS Aligos Therapeutics, Inc. 0.0%
Value $479K Shares 83,055 Est. Cost Unrealized
TYRA Tyra Biosciences, Inc. 0.0%
Value $339K Shares 10,607 Est. Cost Unrealized
SRZNW Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) 0.0%
Value $13,750 Shares 833,333 Est. Cost Unrealized